SCHEMBL28096908

SCHEMBL28096908

CC(=O)OC(C)c1ccc(N(C)C)c(Br)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.45
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TSHR P16473 2/20 0.35
HSD17B10 Q99714 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
CRHR1 P34998 2/20 0.33
GAA P10253 2/20 0.33
MAPK1 P28482 1/20 0.33
FSCN1 Q16658 1/20 0.32
CYP3A4 P08684 1/20 0.31
ALOX5 P09917 1/20 0.31
APP P05067 1/20 0.31
CYP1A2 P05177 1/20 0.31
PGR P06401 1/20 0.31
PTGS1 P23219 1/20 0.31
PDE4A P27815 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28833648 0.81 GAA (0.42) KDM4ETSHRGAA
SCHEMBL27842836 0.79 PGR (0.39) KDM4ETSHRAPPPGRPTGS1
SCHEMBL27570240 0.79 MAPT (0.48) MAPTALDH1A1KDM4EL3MBTL1TSHR
SCHEMBL27669886 0.76 PTGS1 (0.42) MAPTTSHRCYP3A4APPCYP1A2
SCHEMBL17813143 0.76 MAPT (0.50) MAPTCRHR1
SCHEMBL29510759 0.74 CYP1A2 (0.50) ALDH1A1TSHRSMN1; SMN2ALOX5CYP1A2
SCHEMBL5937174 0.74 CYP1A2 (0.50) ALDH1A1TSHRSMN1; SMN2ALOX5CYP1A2
SCHEMBL30616847 0.74 MAPT (0.49) MAPTALDH1A1KDM4EL3MBTL1TSHR
SCHEMBL29510782 0.74 CYP1A2 (0.50) ALDH1A1TSHRSMN1; SMN2ALOX5CYP1A2
SCHEMBL3159375 0.74 MAPT (0.49) MAPTALDH1A1KDM4EL3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104011021-B heterocyclic derivatives and their use as prostaglandin D2 receptor modulators 埃科特莱茵药品有限公司 2016-08-24 CN disclosed